You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 8,192,719


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,192,719 protect, and when does it expire?

Patent 8,192,719 protects MACRILEN and is included in one NDA.

This patent has eleven patent family members in ten countries.

Summary for Patent: 8,192,719
Title:Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds
Abstract: A method of assessing growth hormone deficiency in a human or animal subject, the method comprising administering orally to the subject EP 1572 (Formula I) or EP 1573 (Formula II), obtaining a post-administration sample from the subject, determining the level of growth hormone in the sample and assessing whether the level of growth hormone in the sample is indicative of growth hormone deficiency in the subject. Preferably, the GH level in the sample is measured by immunoassay. Also disclosed is a kit of parts constituting a diagnostic kit comprising: (a) EP 1572 or EP 1573 formulated for oral administration; and (b) means for determining the level of growth hormone in a sample.
Inventor(s): Larsen; Finn (Edinburgh, GB)
Assignee: Aeterna Zentaris GmbH (Frankfurt, DE)
Application Number:12/279,805
Patent Claim Types:
see list of patent claims
Use; Device; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,192,719

Introduction

United States Patent 8,192,719, titled "Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds," is a significant patent in the field of medical diagnostics. This article will delve into the details of the patent's scope, claims, and the broader patent landscape surrounding it.

Patent Overview

Publication Number and Authority The patent, US8192719B2, was issued by the United States Patent and Trademark Office (USPTO) and is categorized under the authority of the United States[4].

Claims Analysis

Independent and Dependent Claims

The patent includes a set of independent and dependent claims that define the scope of the invention. Independent claims are those that stand alone and do not rely on other claims, while dependent claims build upon the independent claims.

  • Independent Claims: These claims outline the core aspects of the invention, such as the method of diagnosing growth hormone deficiency through the oral administration of specific compounds (EP 1572 or EP 1573)[4].
  • Dependent Claims: These claims further specify the details of the method, including the dosage, administration route, and any additional steps or components involved.

Claim Length and Count

Research on patent scope often uses metrics such as independent claim length and count to measure the breadth and clarity of the patent. For US8192719B2, the independent claims are relatively concise, indicating a focused scope. The number of claims also reflects the complexity and specificity of the invention[5].

Patent Scope

Metrics for Measuring Scope

The scope of a patent can be measured using various metrics, including:

  • Independent Claim Length: Longer claims often indicate a broader scope but can also suggest less clarity.
  • Independent Claim Count: A higher number of independent claims can indicate a more complex invention but may also suggest a narrower scope if each claim is highly specific[5].

For US8192719B2, the claims are structured to ensure clarity and specificity, which is crucial for maintaining the validity and enforceability of the patent.

Prior Art and Citations

Prior Art Keywords

The patent lists several prior art keywords, such as "sample," "growth hormone," "subject," "level," and "administration." These keywords help in understanding the context and the existing knowledge in the field at the time of the patent application[4].

Forward Citations

Forward citations, which are citations to the patent by later patents, can indicate the impact and relevance of the invention. A higher number of forward citations often suggests that the patent is influential in its field.

Patent Landscape

Related Patents and Applications

To understand the broader patent landscape, it is essential to look at related patents and applications. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can help identify other patents and applications that are part of the same patent family or cite similar prior art[1].

International Patent Offices

The invention may also have been patented or applied for in other countries. Databases such as the European Patent Office's esp@cenet, the Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE can provide insights into international filings[1].

Legal Status and Expiration

The legal status of the patent is active, but it is set to expire based on the patent term, which is typically 20 years from the filing date of the earliest non-provisional application to which the patent is entitled. It is crucial to verify the exact expiration date through the USPTO or other reliable sources[4].

Economic and Innovation Impact

Patent Maintenance Payments

The maintenance payments required to keep the patent in force can be an indicator of its economic value. Patents that are maintained over their full term often have significant economic impact[5].

Examination Process

The examination process for US8192719B2 would have involved a thorough review by the USPTO to ensure that the claims were novel, non-obvious, and useful. The duration and outcome of the examination process can provide insights into the patent's scope and validity[5].

Conclusion

Understanding the scope and claims of United States Patent 8,192,719 involves a detailed analysis of its independent and dependent claims, prior art, and the broader patent landscape. Here are some key points:

  • Claims Structure: The patent includes specific independent and dependent claims that define the method of diagnosing growth hormone deficiency.
  • Scope Metrics: The use of claim length and count metrics indicates a focused and specific scope.
  • Prior Art and Citations: The patent's prior art keywords and potential forward citations highlight its relevance and impact.
  • Patent Landscape: The patent is part of a larger landscape that includes related patents and international filings.
  • Legal Status: The patent is active but has a defined expiration date.

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the patent's scope.
  • Scope Metrics: Claim length and count are crucial for understanding the patent's breadth and clarity.
  • Prior Art: Keywords and citations provide context and relevance.
  • Patent Landscape: Related patents and international filings are essential for a comprehensive understanding.
  • Legal Status: Verify the patent's active status and expiration date.

FAQs

Q: What is the main invention described in US8192719B2? A: The main invention is a method for diagnosing growth hormone deficiency through the oral administration of EP 1572 or EP 1573 compounds.

Q: How can the scope of a patent be measured? A: The scope can be measured using metrics such as independent claim length and independent claim count.

Q: What are forward citations, and why are they important? A: Forward citations are citations to the patent by later patents and indicate the patent's influence and relevance.

Q: Where can I find information on related international patents? A: Databases such as esp@cenet, the Japan Patent Office, and PATENTSCOPE provide access to international patent filings.

Q: How long is a patent typically in force? A: A patent is typically in force for 20 years from the filing date of the earliest non-provisional application.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. Unified Patents Portal - US-11241483-B2: https://portal.unifiedpatents.com/patents/patent/US-11241483-B2
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US8192719B2: https://patents.google.com/patent/US8192719B2/en
  5. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 8,192,719

Showing 1 to 1 of 1 entries

Foreign Priority and PCT Information for Patent: 8,192,719

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0603295.7Feb 18, 2006
PCT Information
PCT FiledFebruary 19, 2007PCT Application Number:PCT/GB2007/000566
PCT Publication Date:August 23, 2007PCT Publication Number: WO2007/093820

International Family Members for US Patent 8,192,719

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Cyprus 1115080 ⤷  Try for Free
Denmark 1984744 ⤷  Try for Free
European Patent Office 1984744 ⤷  Try for Free
Japan 2009526989 ⤷  Try for Free
Japan 4852728 ⤷  Try for Free
Spain 2404582 ⤷  Try for Free
United Kingdom 0603295 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.